Cannabidiol Attenuates Seizures And Social Deficits In A Mouse Model Of Dravet Syndrome

Key Findings:  Results provide critical preclinical evidence supporting treatment of epilepsy and autistic-like behaviors linked to DS with CBD. The authors also introduce antagonism of GPR55 as a potential therapeutic approach by illustrating its beneficial effects in DS mice. This study provides essential preclinical evidence needed to build a sound scientific basis for increased medicinal use of CBD.

Type of Study:  Animal Study

Study Result:  Positive

Study Location(s):  United States

Year of Pub:  2017

Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Receptors Studied:  GPCR 55